Incyte Stock Story

INCY -  USA Stock  

USD 65.13  3.25  4.75%

Incyte Stock News module provides quick insight into current market opportunities from investing in Incyte Corp. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Incyte Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please see Incyte Corp Hype Analysis, Incyte Corp Correlation and Incyte Corp Performance.

Incyte Today's Stock News 

 
Refresh
Incyte Corp stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Incyte daily returns and investor perception about the current pice of Incyte Corp as well as its diversification or hedging effects on your existing portfolios.
Sale by Dashyant Dhanak of 389 shares of Incyte Corp
Filed transaction by Incyte Corp officer. General open market or private sale of non-derivative or derivative security

Incyte insider trading alert for sale of common stock by Dashyant Dhanak, EVP & Chief Scientific Officer, on 4th of October 2021. This event was filed by Incyte Corp with SEC on 2021-10-04. Statement of changes in beneficial ownership - SEC Form 4. Dashyant Dhanak currently serves as executive vice president chief scientific officer of Incyte Corp

Cash Floor Correlation

Click cells to compare fundamentals

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Incyte Corp Fundamental Analysis

We analyze Incyte Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incyte Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incyte Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

Incyte Corp is currently under evaluation in net income category among related companies. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Incyte Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Incyte Corp stock to make a market-neutral strategy. Peer analysis of Incyte Corp could also be used in its relative valuation, which is a method of valuing Incyte Corp by comparing valuation metrics with similar companies.

Peers

Incyte Corp Related Equities

BBIO
BBIOBridgebio Pharma   13.50   
0%
67.0%
BCAB
BCABBioatla   11.34   
0%
56.0%
BLU
BLUBellus Health   10.62   
0%
52.0%
BTX
BTXBrooklyn Immunotherapeutics   9.25   
0%
46.0%
MBIO
MBIOMustang Bio   6.73   
0%
33.0%
FOLD
FOLDAmicus Therapeutics   5.74   
0%
28.0%
BBI
BBIBrickell Biotech   3.12   
0%
15.0%
MBRX
MBRXMoleculin Biotech CS   0.93   
0%
4.0%
BCDA
BCDABiocardia   0.91   
4.0%
0%
BCLI
BCLIBrainstorm Cell   20.05   
100.0%
0%
Please see Incyte Corp Hype Analysis, Incyte Corp Correlation and Incyte Corp Performance. Note that the Incyte Corp information on this page should be used as a complementary analysis to other Incyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Incyte Stock analysis

When running Incyte Corp price analysis, check to measure Incyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte Corp is operating at the current time. Most of Incyte Corp's value examination focuses on studying past and present price action to predict the probability of Incyte Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte Corp's price. Additionally, you may evaluate how the addition of Incyte Corp to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Incyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte Corp. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Incyte Corp is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte Corp's value that differs from its market value or its book value, called intrinsic value, which is Incyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte Corp's market value can be influenced by many factors that don't directly affect Incyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Incyte Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.